A Study to Evaluate the Safety and Effectiveness of a Silicone Hydrogel Custom Contact Lens When Compared to Alden Optical HP Sphere Lens
- Conditions
- Contact Lens Wear
- First Posted Date
- 2019-04-01
- Last Posted Date
- 2022-11-14
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 84
- Registration Number
- NCT03897712
- Locations
- 🇺🇸
Bausch Site 1, San Francisco, California, United States
🇺🇸Bausch Site 2, Denver, Colorado, United States
🇺🇸Bausch Site 3, Sarasota, Florida, United States
Evaluate the Safety and Effectiveness of the Biotrue ONEday for Astigmatism
- Conditions
- Astigmatism
- First Posted Date
- 2018-09-24
- Last Posted Date
- 2021-01-08
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 242
- Registration Number
- NCT03681808
- Locations
- 🇺🇸
Bausch Site 117, Irvine, California, United States
🇺🇸Bausch Site 107, San Diego, California, United States
🇺🇸Bausch Site 101, San Francisco, California, United States
Evaluate the Safety and Effectiveness of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens
- Conditions
- Cataract
- First Posted Date
- 2018-07-27
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 501
- Registration Number
- NCT03603600
- Locations
- 🇺🇸
Bausch Site 108, Fayetteville, Arkansas, United States
🇺🇸Bausch Site 113, Garden Grove, California, United States
🇺🇸Bausch Site 120, Northridge, California, United States
Bausch & Lomb Ophthalmic Viscosurgical Device (OVD) Dispersive (DVisc40)
- Conditions
- Cataract
- First Posted Date
- 2018-04-30
- Last Posted Date
- 2021-10-22
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 372
- Registration Number
- NCT03511638
- Locations
- 🇺🇸
Valeant Site 01, San Diego, California, United States
A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle
- Conditions
- Allergic Conjunctivitis
- Interventions
- First Posted Date
- 2018-04-06
- Last Posted Date
- 2023-06-08
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 65
- Registration Number
- NCT03489941
- Locations
- 🇺🇸
Total Eye Care, PA, Memphis, Tennessee, United States
Clinical Study of Approved Contact Lenses
- Conditions
- Myopia
- First Posted Date
- 2017-11-22
- Last Posted Date
- 2021-01-08
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 271
- Registration Number
- NCT03351101
- Locations
- 🇺🇸
valeant Site 02, San Diego, California, United States
🇺🇸Valeant Site 03, San Francisco, California, United States
🇺🇸Valeant Site 04, Denver, Colorado, United States
Study to Explore the Pharmacokinetics and Pharmacodynamics of Epinephrine in Healthy Male and Female Subjects With Different Skin to Muscle Depth (STMD)
- Conditions
- Anaphylaxis
- Interventions
- Device: Part 1Device: Part 2 Group 1Drug: Part 2 group 2Device: Part 2 group 3Device: Part 2 Group 4
- First Posted Date
- 2017-09-14
- Last Posted Date
- 2019-06-21
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 43
- Registration Number
- NCT03282929
- Locations
- 🇩🇪
Nuvisan GmbH, Neu-Ulm, Wegenerstrasse 13, Germany
Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant
- Conditions
- Uveitis, Posterior
- First Posted Date
- 2017-05-09
- Last Posted Date
- 2019-06-21
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 3
- Registration Number
- NCT03145025
- Locations
- 🇺🇸
Valeant Site 001, Boston, Massachusetts, United States
Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Installations
- First Posted Date
- 2017-04-04
- Last Posted Date
- 2017-05-18
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 15
- Registration Number
- NCT03098953
- Locations
- 🇺🇸
Valeant Site 01, Inglewood, California, United States
LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
- Conditions
- Ocular InflammationCataractPain
- Interventions
- First Posted Date
- 2016-06-01
- Last Posted Date
- 2021-01-08
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 600
- Registration Number
- NCT02786901
- Locations
- 🇺🇸
Valeant Site 01, Phoenix, Arizona, United States
🇺🇸Valeant Site 03, Oceanside, California, United States
🇺🇸Valeant Site 05, Miami, Florida, United States